Therapeutic Potential of the Prolyl Hydroxylase Inhibitor Roxadustat in a Mouse Hindlimb Lymphedema Model.
Sign Up to like & getrecommendations! Published in 2023 at "Lymphatic research and biology"
DOI: 10.1089/lrb.2022.0071
Abstract: Background: Lymphedema is an intractable disease with no curative treatment available. Conservative treatment is the mainstay, and new drug treatment options are strongly needed. The purpose of this study was to investigate the effect of… read more here.
Keywords: roxadustat; lymphedema; group; hindlimb lymphedema ... See more keywords